Third population-based immune surveillance study for the evaluation of the National Immunisation Programme in the Netherlands: the PIENTER3 study
Completed
- Conditions
- immune systemprotection against infectious diseases10019815
- Registration Number
- NL-OMON42468
- Lead Sponsor
- RIVM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 8400
Inclusion Criteria
* Subject is part of the study sample, aged 0 to 89 years old and has received a personal invitation for the PIENTER3 study.
* Subject has given written Informed Consent (IC) before the start of the study visit.
Exclusion Criteria
None
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The age-specific seroprevalence (immunity) for diseases included in the NIP of<br /><br>the Dutch general population.</p><br>
- Secondary Outcome Measures
Name Time Method <p>The age-specific seroprevalence against other infectious diseases, in<br /><br>particular those that might be vaccine-preventable in the near future and<br /><br>against those diseases with a frequent subclinical course.<br /><br>By collecting additional samples, the relationship between immune status and<br /><br>carriage of potential pathogens, lifestyle factors and environmental factors<br /><br>can be studied.</p><br>